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RESEARCH ARTICLE

The loss of Hh responsiveness by a non-ciliary Gli2 variant
Jinling Liu1, Huiqing Zeng1 and Aimin Liu1,2,*

Hedgehog signaling is crucial for vertebrate development and
physiology. Gli2, the primary effector of Hedgehog signaling,
localizes to the tip of the primary cilium, but the importance of its
ciliary localization remains unclear. We address the roles of Gli2 ciliary
localization by replacing endogenous Gli2 with Gli2ΔCLR, a Gli2 variant
not localizing to the cilium. The resulting Gli2 ΔCLRKI and Gli2 ΔCLRKI;Gli3
double mutants resemble Gli2-null and Gli2;Gli3 double mutants,
respectively, suggesting the lack of Gli2ΔCLR activation in development.
Significantly, Gli2ΔCLR cannot be activated either by pharmacochemical
activation of Smo in vitro or by loss of Ptch1 in vivo. Finally, Gli2ΔCLR
exhibits strong transcriptional activator activity in the absence of Sufu,
suggesting that the lack of its activation in vivo results from a specific
failure in relieving the inhibitory function of Sufu. Our results provide
strong evidence that the ciliary localization of Gli2 is crucial for ciliumdependent activation of Hedgehog signaling.
KEY WORDS: Cilium, Hedgehog signaling, Mouse, Spinal cord, Sufu

INTRODUCTION

The Hedgehog (Hh) family of secreted proteins mediates numerous
inductive events crucial for the proliferation, differentiation and
migration of cells in diverse species ranging from planarian to fruit
flies and vertebrates (Briscoe and Thérond, 2013; Ye and Liu,
2011). Studies in the past decade suggest that Hh signaling in
vertebrates requires the primary cilium, a solitary protrusion on the
surface of most somatic cells implicated in a plethora of human
genetic diseases (Goetz and Anderson, 2010; Nozawa et al., 2013).
However, the molecular mechanisms underlying the connection
between the cilium and Hh signal transduction remain enigmatic.
The vertebrate Hh family of proteins, including Shh, Ihh and
Dhh, interacts with the Patched (Ptch) receptors, especially Ptch1
(Briscoe and Thérond, 2013). This interaction relieves the inhibition
on a G protein-coupled receptor-like protein Smoothened (Smo),
and inhibits the proteolytic processing of zinc-finger transcription
factors Gli2 and Gli3 into repressors. Moreover, high levels of Hh
pathway activation convert the full-length Gli2 and Gli3 into labile
activators, possibly through dissociating them from their negative
regulator suppressor of fused (Sufu) (Humke et al., 2010; Lin et al.,
2014; Tukachinsky et al., 2010). A third member of the Gli family,
Gli1, is expressed in response to the initial activation of the Hh
pathway, bolstering the pathway activation to a higher level.
Hh pathway activation coincides with the exclusion of Ptch1
from, and concomitant accumulation of Smo in, the primary cilium
(Corbit et al., 2005; Rohatgi et al., 2007). The ciliary accumulation
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of Smo appears to be essential, but not sufficient, for its activation
(Corbit et al., 2005; Rohatgi et al., 2009; Wang et al., 2009; Wilson
et al., 2009). All mammalian Gli proteins, as well as Sufu, localize
to the tip of the cilium in a coordinated process, which is further
enhanced by Hh signaling (Chen et al., 2009; Haycraft et al., 2005;
Wen et al., 2010; Zeng et al., 2010b). Disturbing the cytoplasmic
microtubule network or intraflagellar transport (IFT) has been
shown to reduce Gli2 ciliary localization and coincidently disrupt
Hh signaling (Keady et al., 2012; Kim et al., 2009). However, as
cytoskeleton and IFT affect the localization of numerous other
cellular components, these approaches have not adequately
established a connection between Gli2 ciliary localization and Hh
pathway activation.
The molecular mechanisms of Gli activation have been the focus
of inquiry in recent years. cAMP-dependent protein kinase (PKA)
is an essential negative regulator of Gli proteins (Niewiadomski
et al., 2014; Tuson et al., 2011). However, the pathway activation
in the absence of PKA is dependent on the cilium, suggesting that
additional cilium-dependent mechanisms exist downstream of
PKA inhibition to allow Gli activation (Tuson et al., 2011). By
contrast, the removal of Sufu leads to Gli activation even in the
absence of the cilium, and the dissociation between Sufu and Gli
proteins appear to be dependent on the cilium (Chen et al., 2009;
Humke et al., 2010; Jia et al., 2009). These results suggest that the
release of Gli proteins from Sufu inhibition in the cilium is a major
event in Gli activation.
Here, we report that a Gli2 variant, Gli2ΔCLR, fails to localize to
the cilium, but retains intrinsic transcriptional activity and
responds to Sufu inhibition. To determine whether the ciliary
localization is required for Gli2 activation, we generated a
Gli2 ΔCLR knock-in mouse strain in which Gli2 ΔCLR is transcribed
in a similar pattern to endogenous Gli2. We show that Hh signaling
is compromised in Gli2 ΔCLRKI homozygous and Gli2 ΔCLRKI/−
transheterozygous mutants, and is further reduced in Gli2 ΔCLRKI;
Gli3 double mutants, suggesting that Gli2ΔCLR is not properly
activated in development. Supporting the hypothesis that Gli2
ciliary localization is required for its activation by the Hh pathway,
both in vitro pharmacochemical activation of Smo and in vivo loss
of Ptch1 mutation fail to activate Gli2ΔCLR. Finally, we
demonstrate that Gli2ΔCLR is as capable as endogenous Gli2 at
activating Hh target genes in the absence of Sufu, suggesting that
the lack of its activation in vivo results from a failure in its ciliumdependent release from Sufu inhibition by Hh signaling.
RESULTS
Removing mouse Gli2 from the primary cilium without
disrupting its intrinsic transcriptional activity and response
to Sufu

One way to specifically test the role of Gli2 ciliary localization in Hh
pathway activation is to determine whether a Gli2 variant that does
not localize to the cilium can be activated by Hh signaling. To
accomplish this goal, it is essential to make sure that the intrinsic
transcriptional activity of Gli2 is not disrupted by the mutation that
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removes the protein from the cilium. The intrinsic transcriptional
activity of Gli2 can be revealed by overexpression because previous
studies indicated that overexpression of Gli1 or Gli2 overrides the
inhibitory function of Sufu and activates Hh-target genes
independent of the cilium (Chen et al., 2009; Jia et al., 2009). We
have found that a central region of mouse Gli2 (residues 570 to 967,
the ciliary localization region, CLR), immediately downstream of
the zinc-finger DNA-binding domains, was required for the
localization of Gli2 to the tip of the primary cilium (Fig. 1A;
Zeng et al., 2010b). Consistent with our previous results, we found
that the green fluorescent protein (GFP)-tagged Gli2, but not the
variant lacking the CLR, namely Gli2ΔCLR, localized to the tips of
the cilia in mouse embryonic fibroblasts (MEFs) (Fig. 1B,C). In
addition, we found that GFP-Gli2 localized to both the nucleus and
cytoplasm, whereas GFP-Gli2ΔCLR localized predominantly to the
cytoplasm (Fig. 1B,D). We induced Hh signaling by treating the
cells with Smo agonist (SAG). Although the efficient GFP-Gli2
ciliary localization in DMSO-treated cells (100% of 51 cells)
prevented a further increase in the percentage of SAG-treated cells
exhibiting GFP-Gli2 ciliary localization (100% of 50 cells), we did
observe an increase in the amount of GFP-Gli2 at the ciliary tips
when judged by the fluorescence intensity (Fig. 1B,C). By contrast,
SAG treatment failed to induce the ciliary localization of
GFP-Gli2ΔCLR (Fig. 1B,C). Interestingly, SAG treatment appeared
to result in a slight decrease in the nuclear localization of GFP-Gli2,
but in no appreciable change in the predominant distribution of
GFP-Gli2ΔCLR in the cytoplasm (Fig. 1B,D).
Since the repressor, activator and DNA-binding domains were
all intact in Gli2ΔCLR, we expected Gli2ΔCLR to retain intrinsic
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transcriptional activity. To test this, we overexpressed various
amounts of GFP-tagged Gli2 and Gli2ΔCLR in Shh-L2 cells that
stably express a Gli-responsive luciferase reporter gene (Taipale
et al., 2000), and found that GFP-Gli2ΔCLR activated the reporter
gene expression more efficiently than GFP-Gli2, suggesting that
the removal of CLR did not disrupt the intrinsic activator activity of
Gli2 (Fig. 1E). The extra activity of GFP-Gli2ΔCLR could result from
its increased stability because the CLR includes sites that are
required for SCFßTRCP-mediated degradation of Gli2 (Pan et al.,
2006). However, our immunoblot analysis suggested that the
difference between the levels of GFP-Gli2ΔCLR and GFP-Gli2
(<25%; Fig. 1F) could not explain the more than fivefold difference
in activity. Therefore, we conclude that GFP-Gli2ΔCLR exhibits
higher intrinsic transcriptional activator activity than GFP-Gli2.
Sufu is an essential negative regulator of Gli2 and ciliumdependent relief of Gli2 from Sufu inhibition is a crucial event in
Hh pathway activation (Chen et al., 2009; Cooper et al., 2005;
Humke et al., 2010; Jia et al., 2009; Svärd et al., 2006; Tukachinsky
et al., 2010). Consistent with our previous co-immunoprecipitation
analysis that showed physical interaction between Sufu and
Gli2ΔCLR (Zeng et al., 2010b), we found that overexpression of
Sufu inhibits reporter expression activated by Gli2ΔCLR, suggesting
that Gli2ΔCLR remains sensitive to Sufu inhibition (Fig. 1G).
Replacement of Gli2 with Gli2ΔCLR in vivo through a knock-in
approach

As Gli2ΔCLR lacks ciliary localization, but retains its intrinsic
transcriptional activity and its response to Sufu inhibition, we
reasoned that Gli2ΔCLR could be used to test the hypothesis that the
Fig. 1. The non-ciliary Gli2ΔCLR retains
intrinsic transcriptional activity and
response to Sufu. (A) A schematic illustration
of Gli2 and Gli2ΔCLR. Red and green boxes
denote the repressor (R) and activator (A)
domains, respectively. ZF, zinc-finger DNAbinding domain. Numbers indicate the position
of the ciliary localization region (CLR), which is
highlighted in orange. Asterisks indicate the
locations for the primers used in the
qRT-PCR reactions presented in Fig. 2B.
(B) Representative images of GFP-Gli2 and
GFP-Gli2ΔCLR-expressing MEFs treated with
DMSO or Smo agonists (SAG). Acetylated
α-Tubulin reveals the cilia and DAPI reveals the
nuclei. The arrowheads indicate the tips of the
cilia. (C) Statistical analysis of the ciliary
localization of GFP-Gli2 and GFP-Gli2ΔCLR.
**P=7×10−46, χ2-test. (D) Statistical analysis of
the nuclear/cytoplasmic localization of
GFP-Gli2 and GFP-Gli2ΔCLR. *P=0.026,
**P=3×10−19, χ2-test. (E) GFP-Gli2ΔCLR
activates the expression of a Gli-responsive
reporter more efficiently than GFP-Gli2. x-axis:
amount of effector DNA used for transfection.
y-axis: relative luciferase reporter expression,
control sample without effector transfection is
set to 1. (F) Immunoblot analysis on samples
used for the experiment in E. (G) Sufu inhibits
Gli2ΔCLR-activated expression of a Gliresponsive reporter. For E-G, three
independent experiments were performed and
each experiment was carried out in triplicate.
**P<0.01, unpaired Student’s t-test.
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ciliary localization of Gli2 was essential for Hh pathway activation.
Previous studies have indicated that Gli overexpression overrides
the inhibitory function of Sufu and activates Hh target genes
independently of the cilium (Chen et al., 2009; Jia et al., 2009).
Therefore, Gli2ΔCLR needs to be expressed at a near physiological
level to address whether the lack of its ciliary localization affects its
activation by Hh signaling. Therefore, we replaced endogenous Gli2
with Gli2 ΔCLR in vivo through a gene targeting-based ‘knock-in’
approach in mouse embryonic stem (ES) cells such that the
transcription of Gli2 ΔCLR is under the native transcriptional cisregulatory elements of the Gli2 locus. Previous studies have shown
that genes ‘knocked in’ to the same location were expressed in
similar patterns to that of endogenous Gli2 (Bai and Joyner, 2001;
Bai et al., 2004).
In our knock-in DNA construct, ∼110 bp of the first coding exon
of Gli2 (from 73 bases upstream to 38 bases downstream of
endogenous translational start) were replaced with the coding
sequence for Gli2 ΔCLR followed with the entire 3′ untranslated
region of Gli2 and three tandem repeats of 250 bp of SV40 polyA
signal (Fig. 2A; supplementary material Fig. S1A). A neomycinresistance gene expression cassette (neo) flanked with loxP sites was
also inserted to enable drug selection of the correctly targeted ES
cells. We derived Gli2 ΔCLRKIn mice from two independently
targeted ES cell clones, and confirmed the predicted integration of
the targeting constructs into the Gli2 locus through Southern

hybridization and polymerase chain reaction (PCR) (supplementary
material Fig. S1B-E).
To confirm that the levels of Gli2 ΔCLR transcription in Gli2 ΔCLR
knock-in embryos were comparable with that of endogenous Gli2,
we performed quantitative real-time reverse transcriptase PCR
analysis (qRT-PCR) on embryonic day 9.5 (E9.5) embryos. We
found that the level of Gli2 ΔCLR mRNA in Gli2 ΔCLRKIn/ΔCLRKIn
embryos was nearly twice as much as that of endogenous Gli2
(Fig. 2B). Strikingly, immunoblot analysis of Gli2 ΔCLRKIn/ΔCLRKIn
embryos showed a ∼12-fold increase in the level of Gli2ΔCLR
protein compared with that of Gli2 in wild-type embryos (Fig. 2C).
We subsequently removed neoR by breeding Gli2 ΔCLRKIn/+ mice to a
mouse line expressing Cre recombinase in the germline. The levels
of the mRNA (∼70% more than Gli2) and protein (∼8.7-fold of Gli2)
for Gli2ΔCLR in resulting Gli2 ΔCLRKI/ΔCLRKI homozygous mutants
were slightly lower than that in Gli2 ΔCLRKIn/ΔCLRKIn mutant embryos,
but the difference was not statistically significant (Fig. 2B,C).
To make the Gli2ΔCLR protein level more comparable with
endogenous Gli2, we generated transheterozygous embryos by
breeding Gli2 ΔCLRKIn/+ or Gli2 ΔCLRKI/+ heterozygotes to the carriers
of a null allele of Gli2 (Gli2tm2.1Alj; Bai and Joyner, 2001). For
simplicity, we will refer to it as Gli2−. As expected, in Gli2 ΔCLRKIn/− and
Gli2 ΔCLRKI/− transheterozygous embryos, Gli2 ΔCLR was transcribed
at a slightly lower (∼80%) level than that of endogenous Gli2 in
wild-type littermates (Fig. 2B). Consistently, the level of Gli2ΔCLR
1653
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Fig. 2. Replacing endogenous Gli2 with Gli2ΔCLR. (A) The two knock-in alleles used in this study. In Gli2 ΔCLRKIn, the open reading frame of Gli2ΔCLR, along with
the 3′ untranslated region (UTR) of Gli2 and three tandem repeats of SV40 polyA sequence ( pA), replaces 111 bp in the first coding exon of Gli2, followed with a
neomycin expression cassette (neo) flanked with loxP sites. In Gli2 ΔCLRKI, recombination between the two loxP sites removes the neo cassette, leaving a
single loxP site. (B) qRT-PCRs of RNA extracted from E9.5 whole embryos show comparable transcript levels between wild type and the Gli2 ΔCLR knock-in
alleles. n.s., P>0.05, unpaired Student’s t-test. n=3 embryos for each genotype. (C) Immunoblot analysis on E9.5 whole-embryo lysates shows an increase in the
level of the Gli2ΔCLR protein in Gli2 ΔCLR knock-in embryos compared with endogenous Gli2. *P<0.05, unpaired Student’s t-test. (D) Immunofluorescence analysis
of starved mouse embryonic fibroblasts confirmed that Gli2ΔCLR did not localize to the cilium, even in the presence of Smo agonist (SAG). Cilia are labeled with
acetylated α-Tubulin. Nuclei are labeled with DAPI. *P<0.05, χ2-test.
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protein in the transheterozygotes is approximately four times as much
as that of endogenous Gli2 protein in wild-type embryos (Fig. 2C).
We next examined the subcellular localization of Gli2ΔCLR in
Gli2 ΔCLRKIn/ΔCLRKIn homozygous mutant mouse embryonic
fibroblasts (MEFs) through immunofluorescence. Using an
antibody against the N-terminal 416 amino acids of Gli2, we found
that wild-type Gli2, but not Gli2ΔCLR, localizes to the tips of the
primary cilia (Fig. 2D). Treating the wild-type cells with Smo agonist
(SAG) resulted in an increase in Gli2 accumulation at the tips of the
cilia (Fig. 2D). By contrast, Gli2ΔCLR remains absent from the cilia
upon SAG treatment (Fig. 2D).
Abnormal patterning and compromised Hh signaling in the
Gli2ΔCLR knock-in mutant spinal cords

Both Gli2 ΔCLRKIn/+ and Gli2 ΔCLRKI/+ heterozygous mice are viable and
fertile, and do not exhibit any noticeable morphological or behavioral
defects. However, we did not recover any Gli2 ΔCLRKIn/ΔCLRKIn and
Gli2 ΔCLRKI/ΔCLRKI homozygotes or Gli2 ΔCLRKI/− transheterozygotes
at weaning, suggesting that Gli2ΔCLR was incompatible with postnatal
survival.
At E10.5, Gli2 ΔCLRKIn/ΔCLRKIn and Gli2 ΔCLRKI/ΔCLRKI homozygous
and Gli2 ΔCLRKI/− transheterozygous mutant embryos exhibit kinked
mesencephalic flexure morphology (compare Fig. 3A-D) that is
highly reminiscent of Gli2-null homozygous mutants (Fig. 3E). Gli2
plays an important role in the induction of the floor plate and V3
interneurons of the mouse spinal cord (Ding et al., 1998; Matise et al.,
1998). Therefore, we examined the ventral spinal cord patterning of
these embryos to determine whether Gli2ΔCLR exhibits full activity of
Gli2 in development. Foxa2 was expressed strongly in the floor plate
of wild-type spinal cord (Fig. 3F). We found fewer Foxa2-expressing
1654

cells in the Gli2 ΔCLRKIn/ΔCLRKIn homozygous mutant spinal cords
(Fig. 3G). Nkx2.2-expressing V3 interneuron progenitors were
normally located lateral to the floor plate (Fig. 3K). A reduced
number of Nkx2.2-expressing cells were present in the ventral midline
of the Gli2 ΔCLRKIn/ΔCLRKIn homozygous mutant spinal cords
(Fig. 3L). Consistent with the reduction in the floor plate and V3
interneurons, Olig2-expressing motor neuron progenitors, which were
dorsal to V3 interneurons in the wild-type spinal cord (Fig. 3P), were
closer to the ventral midline of the Gli2 ΔCLRKIn/ΔCLRKIn homozygous
mutant spinal cords (Fig. 3Q). Although our qRT-PCR and
immunoblot analyses showed slightly less Gli2 ΔCLR mRNA and
Gli2ΔCLR protein in Gli2 ΔCLRKI/ΔCLRKI than in Gli2 ΔCLRKIn/ΔCLRKIn
homozygous mutants, the Gli2 ΔCLRKI homozygous spinal cords
exhibit the same degree of reduction in floor plate and V3
interneurons, as well as the ventral expansion of the motor neuron
domain (Fig. 3H,M,R).
The defects in floor plate and V3 interneuron induction in the
Gli2 ΔCLRKIn/ΔCLRKIn and Gli2 ΔCLRKI/ΔCLRKI homozygous mutant spinal
cords were similar, but not as severe as the Gli2–/– mutant spinal cord, in
which Foxa2 expression was largely absent (Fig. 3J) and Nkx2.2expressing cells were greatly reduced in number (Fig. 3O), whereas
Olig2 expression was expanded to the ventral midline (Fig. 3T; Ding
et al., 1998; Matise et al., 1998). We reasoned that the difference might
result from the higher than normal levels of the Gli2ΔCLR protein in
these mutants. To test this hypothesis, we examined the spinal cord
development in Gli2 ΔCLRKIn/− and Gli2 ΔCLRKI/− transheterozygous
mutants, in which the levels of Gli2ΔCLR protein were more similar to
that of Gli2 in wild-type embryos. Indeed, these Gli2 ΔCLRKI/−
transheterozygous mutants exhibit smaller floor plate and V3
interneuron domains resembling those in Gli2–/– homozygous
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Fig. 3. Abnormal ventral spinal cord patterning and compromised Hh signaling in Gli2 ΔCLR knock-in mutants. (A-E) Lateral views of E10.5 whole embryos.
Arrowheads indicate the mesencephalic flexure. (F-T) Immunofluorescence images of the E10.5 spinal cords at the thoracic level. Similar patterns were
observed in more posterior regions. Dashed lines outline the spinal cords. Brackets show the expression domains. (F-I) Foxa2 expression is reduced in the
Gli2 ΔCLRKIn/ΔCLRKIn (n=4), Gli2 ΔCLRKI/ΔCLRKI (n=3) and Gli2 ΔCLRKIn/− (n=4) mutant spinal cords. (J) Foxa2 expression is absent in Gli2–/– (n=3) mutant embryos.
(K-O) Nkx2.2 expression is in the ventral midline of the Gli2 ΔCLRKIn/ΔCLRKIn (n=4), Gli2 ΔCLRKI/ΔCLRKI (n=3), Gli2 ΔCLRKIn/− (n=4) and Gli2–/– mutant spinal cords (n=3).
(P-T) Olig2 expression is expanded ventrally in the Gli2 ΔCLRKIn/ΔCLRKIn (n=4) and Gli2 ΔCLRKI/ΔCLRKI (n=3) mutant spinal cords, and is expanded to the ventral
midline in the Gli2 ΔCLRKIn/− (n=4) and Gli2–/– (n=3) mutant spinal cords. (U) Relative expression levels of Gli1 in E9.5 embryos measured with qRT-PCR. n=3 for
each genotype. *P<0.05, unpaired Student’s t-test. (V,W) X-gal-stained E9.5 embryos showing reduced Gli1-lacZ expression in Gli2 ΔCLRKI/ΔCLRKI;Gli1lacZ/+
embryos (n=2) compared with Gli1lacZ/+ embryos (n=5).
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mutants (Fig. 3I,N). Consequently, the motor neuron progenitor
domain expands further into the ventral-most region of the spinal cord
(Fig. 3S).
The ventral patterning defects in Gli2ΔCLRKIn/ΔCLRKIn, Gli2ΔCLRKI/ΔCLRKI
homozygous and Gli2 ΔCLRKI/− transheterozygous mutant spinal
cords suggested that Hh signaling was compromised due to the
failure in Gli2ΔCLR activation. To determine the level of Hh pathway
activation directly, we examined the expression of Gli1, a direct
transcriptional target gene of Hh signaling. Through qRT-PCR, we
found a progressive decrease in the expression level of Gli1 in
Gli2 ΔCLRKIn/ΔCLRKIn, Gli2 ΔCLRKI/ΔCLRKI homozygous, Gli2 ΔCLRKIn/−
transheterozygous and Gli2–/– mutant embryos, suggesting a
reduction in Hh pathway activation (Fig. 3U). To better reveal Gli1
expression in the developing embryos, we examined the expression
of a lacZ reporter gene inserted in the Gli1 locus (Bai et al., 2002). As
reported, the lacZ expression nicely recapitulated the expression
pattern of Gli1 in the ventral CNS, posterior limb buds and the gut
(Fig. 3V). In Gli2 ΔCLRKI/ΔCLRKI homozygous mutant embryos, the
reporter expression was greatly decreased, especially in the midbrain
and anterior hindbrain regions (Fig. 3W). In summary, the Gli2 nulllike brain morphology, abnormal patterning of the ventral neural
tube and reduced Gli1 expression, suggest that Gli2ΔCLR fails to
activate Hh signaling efficiently in embryonic development.
The more severe disruption of Hh signaling in the
transheterozygous mutants (Gli2 ΔCLRKIn/− and Gli2 ΔCLRKI/−) than
the homozygous mutants (Gli2 ΔCLRKIn/ΔCLRKIn and Gli2 ΔCLRKI/
ΔCLRKI
) suggested that the levels of Gli2ΔCLR protein in these
mutants had a noticeable impact on Hh target gene activation. To
minimize this impact, we used the transheterozygous mutants, in
which the level of Gli2ΔCLR protein was more similar to that of
endogenous Gli2, in studies for the rest of this paper.
Gli2ΔCLRKI/−;Gli3−/− double mutants resemble Gli2−/−;Gli3−/−
double mutants

Activated Smo fails to activate Gli2ΔCLR

The Hh receptor Ptch1 and its downstream target Smo both localize to
the primary cilium, and Smo activation is dependent on its ciliary
localization (Corbit et al., 2005; Rohatgi et al., 2007). Local interactions

Fig. 4. Spinal cord patterning in Gli2 ΔCLRKI;Gli3 double mutants
resembles that of Gli2;Gli3 double mutants. (A-C) Lateral views of E9.5
embryos. Arrowheads indicate exencephaly in B,C. (D-O) Immunofluorescent
images of transverse sections through the E9.5 spinal cords at the thoracic
level. Similar patterns were observed in more posterior regions. Dashed lines
outline the spinal cords. Brackets show the expression domains. (D-I) Foxa2
and Nkx2.2 are expressed in the ventral-most regions of the wild-type spinal
cords (n=7; D,G), but are absent in the Gli2 ΔCLRKI/−;Gli3–/– (n=3; E,H) and
Gli2–/–;Gli3–/– (n=4; F,I) double mutant spinal cords. (J-O) Olig2 and Pax6 are
excluded from the ventral-most regions of the wild type (J,M), but not of the
Gli2 ΔCLRKI/−;Gli3–/– (K,N) and Gli2–/–;Gli3–/– (L,O) double mutant spinal cords.

between Smo and a Ci (fly homolog of Gli2)-containing signaling
complex mediate Hh signaling in Drosophila (Briscoe and Thérond,
2013). If local interaction between vertebrate Smo and Gli2 inside the
cilium similarly underlies Gli2 activation by Smo, Smo activation
would not result in the activation of the non-ciliary Gli2ΔCLR. To test
this hypothesis, we treated the Gli2 ΔCLRKIn/ΔCLRKIn mutant MEFs with
SAG. The SAG treatment induced similar ciliary localization of Smo in
wild-type, Gli2–/– and Gli2 ΔCLRKIn/ΔCLRKIn mutant MEFs (data not
shown). It also greatly increased the expression of Hh target gene Gli1
1655
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Although Gli2 ΔCLR knock-in mutants resemble Gli2-null mutants,
the presence of small numbers of Foxa2-expressing floor-plate
cells in the spinal cords of these mutants suggested that Hh pathway
was slightly more activated in Gli2 ΔCLR knock-in mutants than in Gli2null mutants. One explanation for this minor difference is that the
higher level of Gli2ΔCLR protein may sequester negative regulators
such as suppressor of fused (Sufu), lowering the threshold for Gli3
activator to activate Hh target genes. To test whether this is true, we
removed Gli3 from Gli2 ΔCLRKI/− mutants to obtain Gli2 ΔCLRKI/−;Gli3–/–
double mutants. At E9.5, these Gli2 ΔCLRKI/−;Gli3–/– double mutants
(Fig. 4B) exhibit exencephaly, like Gli2–/–;Gli3–/– double mutants
(Fig. 4C). The expression of Foxa2 (Fig. 4E) and Nkx2.2 (Fig. 4H)
was absent in the Gli2 ΔCLRKI/−;Gli3–/– double mutant spinal cord,
similar to Gli2–/–;Gli3–/– double mutants (Fig. 4F,I). Olig2 and Pax6,
which were excluded from the ventral-most region of the wild-type
spinal cord (Fig. 4J,M), were expressed in the ventral spinal cord of
both Gli2 ΔCLRKI/−;Gli3–/– (Fig. 4K,N) and Gli2–/–;Gli3–/– (Fig. 4L,O)
double mutants. The identical morphological and spinal cord
patterning defects in Gli2 ΔCLRKI/−;Gli3 and Gli2–/–;Gli3–/– double
mutants further suggests that Gli2ΔCLR is incapable of transducing
the Hh signal that is crucial for the neural tube development, and the
Gli3 activator likely underlies the partial activation of Hh signaling
in Gli2 ΔCLR knock-in mutants.

in wild-type MEFs (Fig. 5A). By contrast, the expression of Gli1 was
only slightly increased in Gli2–/– and Gli2 ΔCLRKIn/ΔCLRKIn mutant
MEFs, suggesting a disruption of the signal transduction from Smo to
Gli2ΔCLR (Fig. 5A).
To determine whether Smo activation resulted in the activation of
Gli2ΔCLR in vivo, we examined the morphology, Hh target gene
expression and spinal cord patterning in Gli2 ΔCLRKI/−;Ptch1–/–
double mutants. At E9.5, Ptch1–/– mutant embryos failed to turn and
exhibited severe neural tube defects (Fig. 5B; Goodrich et al., 1997).
The turning and neural tube defects were partially rescued in
Gli2 ΔCLRKI/−;Ptch1–/– and Gli2–/–;Ptch1–/– double mutants, and
some double mutants were noticeably larger than Ptch1–/– mutants
(Fig. 5B). Hh target gene Gli1 was expressed in a ventral-to-dorsal
gradient in the E9.5 wild-type spinal cord (Fig. 5C). However, as
reported previously, Gli1 expression in the floor plate, the ventralmost part of the spinal cord, was downregulated by prolonged
exposure to extremely high levels of Shh through a feedback
mechanism (Ribes et al., 2010). Gli1 expression was downregulated
in the entire Ptch1 mutant spinal cord, consistent with very high
levels of Hh pathway activation (Fig. 5C). In Gli2 ΔCLRKI/−;Ptch1–/–
double mutants, Gli1 expression was restored in the dorsal spinal
cord, suggesting that Hh pathway activation was less than that in
Ptch1 mutants (Fig. 5C). Interestingly, the expression pattern of
Gli1 in the Gli2 ΔCLRKI/−;Ptch1–/– double mutant spinal cord was
similar to that in Gli2 ΔCLRKI/−;Ptch1–/– double mutants (Fig. 5C),
suggesting that the reduction of Hh pathway activation in these
mutants resulted from a disruption of Gli2ΔCLR activation.
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Consistent with the extreme activation of Hh signaling, Foxa2and Nkx2.2-expressing cells spread throughout the Ptch1–/– mutant
spinal cord (Fig. 5D). The expression of Pax6 and Olig2 was absent
or restricted to few cells in the dorsal-most part of the spinal cord
(Fig. 5D). Interestingly, both Foxa2- and Nkx2.2-expressing cells
were restricted to the ventral regions of the Gli2 ΔCLRKI/−;Ptch1–/–
double mutant spinal cords, suggesting that Hh pathway activation
in these mutants was insufficient to support the expression of these
two genes in the dorsal spinal cord (Fig. 5D). Consistent with a
reduction of Hh pathway activation, Olig2 and Pax6 expression was
restored in the dorsal two-thirds of the Gli2 ΔCLRKI/−;Ptch1–/– double
mutant spinal cord (Fig. 5D). These changes in spinal cord
patterning in Gli2 ΔCLRKI/−;Ptch1–/– double mutants were similar to
those in Gli2–/–;Ptch1–/– double mutants (Fig. 5D), providing
further support for the inability of Gli2ΔCLR to respond to upstream
Hh pathway activation in vivo.
Gli2ΔCLR is active in the absence of Sufu

The results described thus far indicate that Gli2ΔCLR does not
respond to Hh pathway activation at the levels of Ptch1 or Smo. The
parsimonious explanation for this phenomenon is that a local
interaction at the cilium cannot be established between activated
Smo and Gli2ΔCLR. Alternatively, the deletion of CLR may result in
damage to the intrinsic transcriptional activity of Gli2 that failed to
be detected in our in vitro overexpression analysis. To distinguish
these two possibilities, we investigated whether Gli2ΔCLR can be
activated in the absence of Sufu, the inhibitory action of which on

Fig. 5. Hh signaling fails to activate Gli2ΔCLR in vitro and in vivo. (A) Activation of Smo with SAG greatly increases Gli1 transcription in wild type, but not
in Gli2−/− or Gli2 ΔCLRKIn/ΔCLRKIn mutant MEFs. n=3 independent experiments. **P<0.01, unpaired Student’s t-test. (B) Lateral views of E9.5 embryos. The
Gli2 ΔCLRKI/−;Ptch1–/– double mutant is larger than the Ptch1–/– mutant, and the Gli2−/−;Ptch1–/– mutant has completed turning. (C) RNA in situ hybridization
images of transverse sections through the E9.5 spinal cords. Gli1 expression was inhibited by the high level of Hh signaling in the Ptch1–/– mutant spinal cord
(n=4), but was present in the dorsal half of the Gli2 ΔCLRKI/−;Ptch1–/– (n=4) and Gli2−/−;Ptch1–/– (n=4) double mutant spinal cords. Dashed lines outline the spinal
cords. Brackets show the expression domains. (D) Immunofluorescent images of transverse sections through the E9.5 spinal cords at the thoracic level. Similar
patterns were observed in more posterior regions. Foxa2 and Nkx2.2 are expressed throughout the spinal cord, whereas Olig2 and Pax6 expression is absent in
Ptch1 mutants (n=3). By contrast, Foxa2, Nkx2.2 and Olig2 expression is restricted to the ventral parts of the Gli2 ΔCLRKI/−;Ptch1–/– (n=3) and Gli2−/−;Ptch1–/–
(n=2) double mutant spinal cords. Pax6 expression is also restored in the Gli2 ΔCLRKI/−;Ptch1–/– and Gli2−/−;Ptch1–/– mutant spinal cords. Dashed lines outline the
spinal cords. Brackets show the expression domains.
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(Fig. 6C). In addition, Olig2 and Pax6 expression remained dorsally
restricted in the Gli2 ΔCLRKI/−;Sufu–/– double mutant spinal cord, as
seen in Sufu–/– mutants (Fig. 6C). The similarity between Sufu–/–
mutant and Gli2 ΔCLRKI/−;Sufu–/– double mutant spinal cord patterning
suggests that Gli2ΔCLR retains its intrinsic transcriptional activity that
can be released by the removal of Sufu.
We and others have previously shown that the protein levels of
Gli2 and Gli3 decrease in Sufu–/– embryos, possibly due to Cullin3/
Spop (speckle type POZ protein)-mediated proteasomal degradation
(Chen et al., 2009; Jia et al., 2009; Wang et al., 2010). To determine
whether Gli2ΔCLR is under the same regulation, we performed
immunoblot analyses on E9.5 whole-embryo lysates. Interestingly,
although the level of Gli2ΔCLR in Gli2 ΔCLRKI/− mutant embryos was
approximately fourfold higher than Gli2 in wild-type embryos, it
was decreased drastically in Gli2 ΔCLRKI/−;Sufu–/– double mutants
such that it was comparable with that of Gli2 in Sufu–/– mutants
(Fig. 6D). Therefore, the widespread activation of Hh signaling in
Gli2 ΔCLRKI/−;Sufu–/– results from its uncompromised intrinsic
transcriptional activity, rather than from an artifact of high protein
level.
DISCUSSION

An essential role for the primary cilium in Hh pathway and Gli
protein activation has been well established by numerous genetic
studies in various vertebrate species in the past decade (Nozawa
et al., 2013). However, the role of the ciliary localization of Gli

Fig. 6. The intrinsic transcriptional activator activity was not disrupted in Gli2ΔCLR. (A) Lateral views of E9.5 embryos showing similar exencephaly and
turning defects in Sufu–/– and Gli2 ΔCLRKI/−;Sufu–/– double mutants. (B) Transverse sections of E9.5 embryos processed for RNA in situ hybridization. The
expression of Hh target gene Gli1 is dorsally restricted in Sufu–/– (n=3) and Gli2 ΔCLRKI/−;Sufu–/– double mutant (n=4) spinal cords. (C) Transverse sections of E9.5
embryos processed for immunofluorescent analysis. Shown are sections at the thoracic level. Similar patterns were observed in more posterior regions. The
expression domains of Foxa2 and Nkx2.2 are expanded into the dorsal spinal cords of Sufu–/–mutant (n=4) and Gli2 ΔCLRKI/−;Sufu–/– double mutant (n=4) spinal
cords. Olig2 expression is shifted dorsally in Sufu–/– mutant and Gli2 ΔCLRKI/−;Sufu–/– double mutant spinal cords. Pax6 expression is restricted to the dorsal-most
part of Sufu–/– mutant and Gli2 ΔCLRKI/−;Sufu–/– double mutant spinal cords. (D) Immunoblot analysis shows decrease in both Gli2 and Gli2Δ CLR protein levels in the
absence of Sufu. **P<0.01, n.s., P>0.05, unpaired Student’s t-test.

1657

DEVELOPMENT

Gli2 can be relieved only through a cilium-dependent process under
physiological condition (Kim et al., 2009).
As reported previously, Sufu–/– mutants failed to turn and
exhibited severe neural tube defects (Fig. 6A; Cooper et al., 2005;
Svärd et al., 2006). There was no obvious rescue of these defects in
Gli2 ΔCLRKI/−;Sufu–/– double mutants (Fig. 6A). The expression of
Hh target gene Gli1 was restricted to the dorsal spinal cords of both
Sufu–/– mutants and Gli2 ΔCLRKI/−; Sufu–/– double mutants (Fig. 6B),
suggesting that Gli2ΔCLR is capable of activating target gene
expression in the absence of Sufu. Furthermore, these results also
suggest that the disruption of Gli2ΔCLR activation in Gli2 ΔCLR
knock-in mutants results from failure to release Gli2ΔCLR from Sufu
inhibition.
Consistent with the widespread activation of Hh signaling, Foxa2
and Nkx2.2 expression domains greatly expanded in the E9.5 Sufu–/–
mutant spinal cord (Fig. 6C). Meanwhile, the expression domains of
Olig2 and Pax6 were shifted dorsally in the Sufu–/– mutant spinal
cord (Fig. 6C). We have recently shown that removing Gli2 from
Sufu mutants, as in Gli2–/–;Sufu–/– double mutants, led to the
absence of Foxa2 and Nkx2.2 expression, along with ventral
expansion of the Olig2 and Pax6 expression, suggesting that Gli2
was the primary activator of Hh signaling in the absence of Sufu
(Liu et al., 2012). In striking contrast to the absence of Foxa2 and
Nkx2.2 expression in Gli2–/–;Sufu–/– double mutants, these two
genes were expressed in most cells of the Gli2 ΔCLRKI/−;Sufu–/–
double mutant spinal cord, similar to that of Sufu–/– mutants
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proteins in their activation has not yet been determined. One
commonly taken approach to address this issue has been to disrupt
the cellular and/or ciliary transport machinery. In one such study, the
disruption of the cytoplasmic microtubule network through a drug
treatment abolished the ciliary localization of Gli2 and disrupted the
Hh signaling (Kim et al., 2009). Similarly, mutations in a
microtubule motor protein Kif7, or in an intraflagellar transport
protein Ift25, affected Gli2 ciliary localization and Hh pathway
activation (Cheung et al., 2009; Endoh-Yamagami et al., 2009; He
et al., 2014; Keady et al., 2012; Liem et al., 2009). One major
concern with this approach is that additional proteins and processes
affected by the disruption of cytoskeleton or transport machinery
may contribute to the observed disruption of Hh signaling.
Moreover, the Gli ciliary localization was only partially affected
by many of these mutations, further complicating the interpretation
of the results.
A more-targeted approach to study the role of the ciliary
localization of Gli2 in its activation is to determine whether a nonciliary variant of Gli2 can be activated by Hh signaling. It is
crucial, however, to distinguish between the inability to respond to
Hh pathway activation and the damage to the intrinsic
transcriptional activity of the non-ciliary variant of Gli2. For
example, a recent study found that the ciliary localization of a Gli2
variant lacking residues 852-1183 was greatly compromised
compared with the full-length Gli2 (Santos and Reiter, 2014).
However, this Gli2 variant acted as a transcriptional repressor
when it was overexpressed, suggesting that the deletion has
damaged its intrinsic transcriptional activator activity. Therefore, it
could not be used to properly investigate the roles of the ciliary
localization of Gli2 in its activation by Hh signaling.
In the current study, we address the relationship between Gli2
ciliary localization and activation using Gli2ΔCLR, a non-ciliary
variant of Gli2. Through the study of Gli2 ΔCLR knock-in mutant
cells and embryos, we show that Gli2ΔCLR fails to respond to Hh
pathway activation at the levels of Ptch1 or Smo. To rule out the
possibility that the intrinsic transcriptional activity of Gli2 is
disrupted in Gli2ΔCLR, we first show that its overexpression is
sufficient to activate a Gli-responsive reporter expression in cultured
cells. In addition, we show that Gli2ΔCLR can support the same level
of Hh pathway activation as endogenous Gli2 in the absence of
Sufu. Therefore, the lack of Gli2ΔCLR activation in Gli2 ΔCLR knockin mutant embryos likely results from the failure in ciliumdependent relief of the inhibitory action of Sufu, not the
disruption of intrinsic transcriptional activity of Gli2.
The simultaneous loss of ciliary localization of Gli2ΔCLR and the
failure in the relief of the inhibitory action of Sufu on this nonciliary variant of Gli2 strongly suggest that the ciliary localization of
Gli2 is crucial for the Hh-dependent activation of this protein.
However, we cannot formally rule out the possibility that the CLR
may also be important for potential conformational changes of Gli2
that allow its dissociation from Sufu, which could be independent of
the loss of Gli2 ciliary localization. To formally establish the
causative relationship between the ciliary localization and activation
of Gli2, it would be ideal to investigate whether restoring the ciliary
localization of Gli2ΔCLR with an unrelated ciliary-localization motif
would allow normal Hh signaling. However, this could prove to be
difficult because Gli2 appears to dynamically traffic through a
special ciliary tip compartment, thus simply directing Gli2ΔCLR
localization to the cilium may not be sufficient to restore its response
to Hh signaling (He et al., 2014).
Previous studies have shown that cilium-dependent regulation of
Hh signaling was dependent on the proper levels of Gli proteins
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(Chen et al., 2009; Jia et al., 2009). Overexpression of Gli1 or Gli2
bypasses the inhibitory regulation of Sufu, thus activating the Hh
pathway independently of the cilium. Therefore, we were concerned
about the approximately fourfold difference between the Gli2ΔCLR
protein level in Gli2 ΔCLRKI/− transheterozygous mutant embryos
and the Gli2 protein level in wild type. Interestingly, despite the
increase in Gli2ΔCLR protein levels, we observed decreased Hh
signaling in Gli2 ΔCLRKI/− transheterozygous mutants. This suggests
that Sufu is likely present in large excess compared with Gli
proteins, as previously reported in fruit flies (Farzan et al., 2009). In
effect, this increase in Gli2ΔCLR protein levels helps to clarify that it
is the lack of activation, rather than insufficient amount of protein,
that underlies the Hh signaling defects in Gli2 ΔCLRKI mutants.
cAMP-dependent protein kinase (PKA) plays an essential
negative role in Hh signaling (Tuson et al., 2011). A recent
study showed that overexpressing a Gli2 variant lacking six PKA
sites highly activates Hh pathway in cultured cells and chicken
spinal cords (Niewiadomski et al., 2014). The non-ciliary
Gli2ΔCLR variant we studied here also lacks all six PKA sites,
and yet it fails to activate Hh pathway in Gli2 ΔCLRKI mutant
embryos. It was recently reported that Hh pathway activation in the
absence of PKA remained cilium dependent (Tuson et al., 2011).
Therefore, it is likely that even a PKA-insensitive Gli2 variant
requires ciliary localization to be activated. Again, it is worth
noting that the activity of any Gli2 variant has to be determined in
a system in which the level of the Gli2 variant is not high enough
to override the intricate regulatory mechanisms involving the
cilium and Sufu, as we have demonstrated here and in previous
studies (Chen et al., 2009; Jia et al., 2009).

Fig. 7. The ciliary localization of Gli2 is essential for its activation. (A) In
wild-type cells, activated Smo interacts with Gli2 and Sufu inside the cilium,
releasing Gli2 from Sufu inhibition. (B) In Gli2 ΔCLR knock-in mutant cells,
Gli2ΔCLR fails to enter the cilium to interact with activated Smo, and remains
inhibited by Sufu.

DEVELOPMENT

RESEARCH ARTICLE

RESEARCH ARTICLE

It is surprising that Gli2ΔCLR exhibits higher intrinsic
transcriptional activity than Gli2 in our luciferase reporter
assay, despite its predominant cytoplasmic localization. It is
possible that the removal of inhibitory post-translational
modification may underlie this increase in transcriptional activity.
For example, the acetylation of K518 in Gli1 has been shown to
inhibit its transcriptional activity (Canettieri et al., 2010). The
corresponding lysine in Gli2, K740, was removed in Gli2ΔCLR,
which could contribute to the increase in its intrinsic transcriptional
activity.
In summary, we show here that Hh signaling fails to activate a
non-ciliary Gli2ΔCLR variant in vivo by relieving the inhibitory
actions of Sufu. Based on our results, we propose that the ciliary
localization of Gli2 allows its activation, likely through local
interaction with activated Smo that relieves Gli2 from its inhibitor
Sufu (Fig. 7A). However, Gli2ΔCLR is under constitutive inhibition
by Sufu because it fails to travel to the cilium to interact with
activated Smo (Fig. 7B). An exciting future direction would be to
reveal the molecular events that directly lead to the activation of Gli2
once it is inside the cilium.
MATERIALS AND METHODS
Tissue culture, transfection and immunofluorescence

Mouse embryonic fibroblasts were prepared from E11.5 embryos as previously
described (Jia et al., 2009). Cells were transfected with Lipofectamine
2000 (Life Technologies), JetPrime (Polyplus-Transfection) or PEI
(Polysciences) according to the manufacturer’s recommendations.
Immunofluorescence analyses were carried out as previously reported (Zeng
et al., 2010b). Antibodies used were acetylated α-tubulin (Sigma-Aldrich,
T7451, 1:1000), GFP (Life Technologies, A11122, 1:1000) and Gli2 (R&D
Systems, AF3635, 1:500, raised against the N-terminal 416 amino acids of
mouse Gli2).
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Animals

E14 mouse embryonic stem (ES) cells (MMRRC) were transfected with
linearized Gli2 ΔCLRKIn targeting construct using a BioRad GenePulsor
electroporation system as described previously (Zeng et al., 2010a).
Genomic DNAs from G418-resistant ES cell clones were cut with Asp718
(Roche) and screened through Southern blot analyses using a 5′ external
probe. Genomic DNAs from the targeted clones were cut with BamHI and
screened again through Southern blot using a 3′ external probe. The
homologous recombination events were further confirmed with PCR using
locus-specific primers. Two targeted Gli2 ΔCLRKIn ES cell clones were
injected into C57/BL6 blastocysts (Charles River Labs). The resulting male
chimeras and their male descendants were bred to wild-type 129 or C3H
females (Charles River Labs). The genotypes of Gli2 ΔCLRKIn and Gli2 ΔCLRKI
mice and embryos were determined with PCR using previously described
primers (Bai and Joyner, 2001).
Other mutant mouse strains used in this study include Gli1tm2Alj (Bai et al.,
2002), Gli2tm2.1Alj (Bai and Joyner, 2001), Gli3Xt-J (Büscher et al., 1998),
Ptch1tm1Mps (Goodrich et al., 1997) and Sufutm1Rto (Svärd et al., 2006), and
were genotyped as described. The use of the animals in this work was
approved by the IACUC at the Penn State University (PA, USA).
Immunohistochemistry and RNA in situ hybridization

Immunohistochemistry using Cy3-labeled secondary antibodies as well as
RNA in situ hybridization using DIG-labeled RNA probes were described
by Liu et al. (2012). Antibodies used were Foxa2 (DHSB, 1:40), Nk2.2
(DHSB, 1:20), Pax6 (DSHB, 1:500) and Olig2 (Millipore, AB9610,
1:1000).
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